4.5 Review

The Prophylactic Use of Glycoprotein 2b/3a Inhibitors in the Endovascular Treatment of Intracranial Aneurysms: A Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Article Neuroimaging

Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey

Jildaz Caroff et al.

Summary: This nationwide survey highlights the significant heterogeneity in clinical practices across centers in the use of antithrombotic therapies. There is a pressing need for trials and guidelines to further evaluate and harmonize antithrombotic regimens in the neurointerventional field.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Article Clinical Neurology

The safety and efficacy of a low dose of tirofiban for early complications during and after stent-assisted coiling of ruptured intracranial aneurysms: A propensity matching study

Guangchen Shen et al.

Summary: Intravenous administration of a low dose of tirofiban may be a safe and effective alternative to dual antiplatelet therapy for stent-assisted coiling of ruptured intracranial aneurysms, showing similar clinical outcomes.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Article Clinical Neurology

Safety and efficacy of intravenous tirofiban for stent-assisted coiling in acutely ruptured intracranial aneurysms: A single center experience

Yihui Ma et al.

Summary: This study established a new protocol for prophylactic tirofiban application during endovascular treatment of ruptured intracranial aneurysms with no oral antiplatelet medications, showing low risks of hemorrhagic or thromboembolic complications. Tirofiban appears to be a safe and alternative option during the stent-assisted coiling of ruptured intracranial aneurysms.

INTERVENTIONAL NEURORADIOLOGY (2022)

Article Clinical Neurology

The safety and efficacy of low-dosage tirofiban for stent-assisted coiling of ruptured intracranial aneurysms

Yazhou Yan et al.

Summary: This study evaluated the safety and efficacy of reducing the dosage of tirofiban for the ruptured aneurysms with SAC. The half-dose tirofiban treatment was associated with a decrease in the prevalence of intracranial hemorrhage but no increase in thromboembolic events compared with those in standard-dose tirofiban treatment. Overall, intravenous tirofiban for SAC of acutely ruptured intracranial aneurysms was found to be feasible and safe.

NEUROSURGICAL REVIEW (2021)

Article Neuroimaging

Prophylactic administration of tirofiban for preventing thromboembolic events in flow diversion treatment of intracranial aneurysms

Qiaowei Wu et al.

Summary: Prophylactic administration of tirofiban combined with conventional dual antiplatelet therapy appears to be safe and efficient for preventing thromboembolic events during flow diverter treatment of unruptured intracranial aneurysms. Balloon angioplasty and longer procedure time are associated with a higher risk of thromboembolic events.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2021)

Article Clinical Neurology

The Prophylactic Use of Tirofiban versus Oral Antiplatelet Medications in Stent-Assisted Coiling of Intracranial Aneurysms: A Meta-analysis

Y. Xiang et al.

Summary: The study analyzed the safety and efficacy of prophylactic tirofiban administration compared with oral antiplatelet drug therapy in patients with cerebral aneurysms. Results showed that tirofiban treatment significantly reduced thromboembolic complications without increasing hemorrhagic events or mortality. Prophylactic therapy with tirofiban may be a more effective approach for patients with cerebral aneurysms.

AMERICAN JOURNAL OF NEURORADIOLOGY (2021)

Article Health Care Sciences & Services

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in systematic review methodology, with modifications in structure and presentation for easier implementation.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Article Neuroimaging

Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results

Ricardo A. Hanel et al.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2020)

Review Virology

Mast cell mediators in relation to dengue severity: A systematic review and meta-analysis

Nourin Ali Sherif et al.

REVIEWS IN MEDICAL VIROLOGY (2020)

Article Clinical Neurology

Tirofiban Protocol Protects Against Delayed Cerebral Ischemia: A Case-Series Study

Mario Zanaty et al.

NEUROSURGERY (2020)

Article Health Care Sciences & Services

Single-arm Trials With External Comparators and Confounder Misclassification How Adjustment Can Fail

Michael Webster-Clark et al.

MEDICAL CARE (2020)

Article Clinical Neurology

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms

Edgar A. Samaniego et al.

STROKE AND VASCULAR NEUROLOGY (2019)

Article Clinical Neurology

SCENT Trial: One-Year Outcomes

Philip M. Meyers et al.

STROKE (2019)

Article Clinical Neurology

A New Protocol for Anticoagulation With Tirofiban During Flow Diversion

Nohra Chalouhi et al.

NEUROSURGERY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial

Tibor Becske et al.

RADIOLOGY (2013)

Article Medicine, General & Internal

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)